UBC9-associated SUMOylation contributes to β-catenin activation and kidney fibrosis
Kidney International · 2025-10 · 108 (4) · 642-657
DOI: 10.1016/j.kint.2025.07.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney International, 2025-10. Verfasst von Juan Cai und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Hunan Key Laboratory of Kidney Disease and Blood Purification, Second Xiangya Hospital at Central South University, Changsh…. Hauptthemen laut MEDLINE: Ubiquitin-Conjugating Enzymes, beta Catenin, Sumoylation, Kidney. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NIDDK NIH HHS, Youth Science Fund Project.
Abstract (Originalsprache)
INTRODUCTION: SUMOylation is a form of post-translational modification that conjugates a small ubiquitin-like modifier (SUMO) to specific lysine residues of target proteins. The role and regulation of SUMOylation in kidney physiology and pathogenesis are largely unknown. Here, we report that SUMOylation promotes kidney fibrosis by enhancing β-catenin signaling. METHODS: UBC9, the sole E2 conjugating enzyme in SUMOylation, was ablated from proximal tubules to determine the role of SUMOylation in mouse kidney fibrosis after obstructed nephropathy or ischemia-reperfusion injury. Point mutations were introduced to identify the SUMOylation sites in β-catenin. RESULTS: UBC9 was induced in tissues from patients with obstructive or IgA nephropathies and in mouse fibrotic kidneys. Kidney fibrosis in mouse models was alleviated by pharmacological inhibitors of SUMOylation or by UBC9 knockout from kidney proximal tubules. Consistently, knockdown of UBC9 attenuated transforming growth factor-β-induced fibrotic changes in kidney tubular cells in vitro. Mechanistically, fibrotic stress increased the SUMOylation of β-catenin, which contributed to the stability and activation of β-catenin. We further identified three SUMOylation sites in β-catenin, the mutation of which reduced the stability and activation of β-catenin during fibrotic stress. CONCLUSIONS: Our results unveil a novel role of SUMOylation in kidney fibrogenesis by activating β-catenin, suggesting a new anti-fibrosis strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Hunan Key Laboratory of Kidney Disease and Blood Purification, Second Xiangya Hospital at Central South University, Changsha, China. Electronic address: cjane218@csu.edu.cn.
- Department of Nephrology, Hunan Key Laboratory of Kidney Disease and Blood Purification, Second Xiangya Hospital at Central South University, Changsha, China.
- Department of Urinary Surgery, Second Xiangya Hospital at Central South University, Changsha, China.
- Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory of Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Diabetes Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Doha, Qatar.
- Department of Nephrology, Hunan Key Laboratory of Kidney Disease and Blood Purification, Second Xiangya Hospital at Central South University, Changsha, China; Department of Cellular Biology and Anatomy, Medical College…
Förderung
- BLRD VA
- NIDDK NIH HHS
- Youth Science Fund Project
- Fundamental Research Funds for Central Universities of the Central South University
- National Institutes of Health
- U.S. Department of Veterans Affairs
- National Natural Science Foundation of China
Zitieren
APA
Cai, J., Wei, J., Zeng, Y., Yi, M., Zhou, Y., Ai, K., Chen, W., Liu, Y., Chen, G., Chen, A., Sun, L., Liu, H., Duan, S., Cheng, J., Wang, C. Y., & Dong, Z. (2025). UBC9-associated SUMOylation contributes to β-catenin activation and kidney fibrosis. Kidney International, 108(4), 642-657. https://doi.org/10.1016/j.kint.2025.07.005
Vancouver
Cai J, Wei J, Zeng Y, Yi M, Zhou Y, Ai K, et al. UBC9-associated SUMOylation contributes to β-catenin activation and kidney fibrosis. Kidney International. 2025;108(4):642-657. doi:10.1016/j.kint.2025.07.005
BibTeX
@article{Cai2025,
author = {Cai, Juan and Wei, Jingzhen and Zeng, Yuqing and Yi, Min and Zhou, Yunqian and Ai, Kai and Chen, Wei and Liu, Yu and Chen, Guochun and Chen, Anqun and Sun, Lin and Liu, Hong and Duan, Shaobin and Cheng, Jinke and Wang, Cong-Yi and Dong, Zheng},
title = {UBC9-associated SUMOylation contributes to β-catenin activation and kidney fibrosis},
journal = {Kidney International},
year = {2025},
volume = {108},
number = {4},
pages = {642--657},
doi = {10.1016/j.kint.2025.07.005}
}
EUVIMED